CRL logo

CRL Long Term Debt

Annual Long Term Debt

$2.72 B
-$342.39 M-11.17%

December 28, 2024


Summary


Performance

CRL Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRLbalance sheetmetrics:

Quarterly Long Term Debt

$2.72 B
-$35.49 M-1.29%

December 28, 2024


Summary


Performance

CRL Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRLbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

CRL Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.2%-4.0%
3 y3 years-6.6%-4.0%
5 y5 years+38.6%-4.0%

CRL Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.1%at low-19.0%at low
5 y5-year-12.1%+38.6%-19.0%+38.6%
alltimeall time-12.1%>+9999.0%-19.0%+1647.6%

Charles River Laboratories International Long Term Debt History

DateAnnualQuarterly
Dec 2024
$2.72 B(-11.2%)
$2.72 B(-1.3%)
Sep 2024
-
$2.76 B(-2.8%)
Jun 2024
-
$2.84 B(-7.8%)
Mar 2024
-
$3.08 B(+0.4%)
Dec 2023
$3.07 B(-1.0%)
$3.07 B(+5.6%)
Sep 2023
-
$2.90 B(-5.7%)
Jun 2023
-
$3.08 B(-2.6%)
Mar 2023
-
$3.16 B(+2.1%)
Dec 2022
$3.10 B(+6.2%)
$3.10 B(-6.3%)
Sep 2022
-
$3.31 B(-1.7%)
Jun 2022
-
$3.36 B(+14.4%)
Mar 2022
-
$2.94 B(+0.8%)
Dec 2021
$2.92 B(+39.9%)
$2.92 B(-7.0%)
Sep 2021
-
$3.14 B(+5.7%)
Jun 2021
-
$2.97 B(+24.9%)
Mar 2021
-
$2.38 B(+13.9%)
Dec 2020
$2.09 B(+6.1%)
$2.09 B(-1.4%)
Sep 2020
-
$2.11 B(-10.2%)
Jun 2020
-
$2.35 B(-4.3%)
Mar 2020
-
$2.46 B(+25.1%)
Dec 2019
$1.97 B(+20.1%)
$1.97 B(-1.7%)
Sep 2019
-
$2.00 B(-6.9%)
Jun 2019
-
$2.15 B(+30.2%)
Mar 2019
-
$1.65 B(+0.8%)
Dec 2018
$1.64 B(+46.9%)
$1.64 B(-1.0%)
Sep 2018
-
$1.65 B(-8.0%)
Jun 2018
-
$1.80 B(+59.0%)
Mar 2018
-
$1.13 B(+1.4%)
Dec 2017
$1.11 B(-7.7%)
$1.11 B(-3.6%)
Sep 2017
-
$1.16 B(+3.6%)
Jun 2017
-
$1.12 B(-4.6%)
Mar 2017
-
$1.17 B(-3.1%)
Dec 2016
$1.21 B(+42.8%)
$1.21 B(-2.1%)
Sep 2016
-
$1.23 B(-7.4%)
Jun 2016
-
$1.33 B(+58.4%)
Mar 2016
-
$840.48 M(-0.7%)
Dec 2015
$846.00 M(+14.2%)
$846.00 M(+1.2%)
Sep 2015
-
$835.80 M(+10.7%)
Jun 2015
-
$754.78 M(+0.0%)
Mar 2015
-
$754.53 M(+1.9%)
Dec 2014
$740.56 M(+15.3%)
$740.56 M(-1.9%)
Sep 2014
-
$754.80 M(-3.4%)
Jun 2014
-
$781.62 M(+27.3%)
Mar 2014
-
$614.13 M(-4.4%)
Dec 2013
$642.35 M(+21.9%)
$642.35 M(+2.9%)
Sep 2013
-
$624.31 M(+0.7%)
Jun 2013
-
$619.77 M(+19.6%)
Mar 2013
-
$518.03 M(-1.7%)
Dec 2012
$527.14 M
$527.14 M(-2.9%)
Sep 2012
-
$543.14 M(-1.5%)
Jun 2012
-
$551.40 M(-18.3%)
DateAnnualQuarterly
Mar 2012
-
$674.74 M(-4.0%)
Dec 2011
$703.19 M(+4.9%)
$703.19 M(-2.4%)
Sep 2011
-
$720.48 M(-1.5%)
Jun 2011
-
$731.42 M(-3.9%)
Mar 2011
-
$761.29 M(+13.6%)
Dec 2010
$670.27 M(+46.5%)
$670.27 M(-4.4%)
Sep 2010
-
$701.08 M(+71.2%)
Jun 2010
-
$409.44 M(-6.5%)
Mar 2010
-
$437.91 M(-4.3%)
Dec 2009
$457.42 M(-15.4%)
$457.42 M(-1.4%)
Sep 2009
-
$463.75 M(-4.7%)
Jun 2009
-
$486.49 M(+2.6%)
Mar 2009
-
$474.15 M(-12.3%)
Dec 2008
$540.65 M(+11.5%)
$540.65 M(+78.0%)
Sep 2008
-
$303.68 M(-2.7%)
Jun 2008
-
$312.26 M(-34.4%)
Mar 2008
-
$476.37 M(-1.8%)
Dec 2007
$485.00 M(-11.3%)
$485.00 M(-1.8%)
Sep 2007
-
$493.70 M(-3.5%)
Jun 2007
-
$511.82 M(-3.0%)
Mar 2007
-
$527.55 M(-3.6%)
Dec 2006
$547.08 M(+110.5%)
$547.08 M(-5.1%)
Sep 2006
-
$576.54 M(+0.8%)
Jun 2006
-
$571.81 M(+111.3%)
Mar 2006
-
$270.65 M(+4.1%)
Dec 2005
$259.90 M(-57.1%)
$259.90 M(-12.7%)
Sep 2005
-
$297.73 M(-8.6%)
Jun 2005
-
$325.68 M(-44.4%)
Mar 2005
-
$585.77 M(-3.3%)
Dec 2004
$605.98 M(+226.4%)
$605.98 M(+225.9%)
Sep 2004
-
$185.96 M(-0.1%)
Jun 2004
-
$186.14 M(-0.0%)
Mar 2004
-
$186.23 M(+0.3%)
Dec 2003
$185.68 M(-3.5%)
$185.68 M(-2.1%)
Sep 2003
-
$189.76 M(-0.1%)
Jun 2003
-
$189.87 M(+0.0%)
Mar 2003
-
$189.85 M(-1.4%)
Dec 2002
$192.48 M(+23.5%)
$192.48 M(+2.1%)
Sep 2002
-
$188.59 M(-0.2%)
Jun 2002
-
$189.05 M(-27.2%)
Mar 2002
-
$259.52 M(+66.5%)
Dec 2001
$155.87 M(-23.0%)
$155.87 M(-19.5%)
Sep 2001
-
$193.65 M(-4.0%)
Jun 2001
-
$201.71 M(-12.6%)
Mar 2001
-
$230.71 M(+13.9%)
Dec 2000
$202.50 M(-47.1%)
$202.50 M(-0.1%)
Sep 2000
-
$202.78 M(-48.4%)
Jun 2000
-
$393.36 M(+0.7%)
Mar 2000
-
$390.46 M
Dec 1999
$382.50 M(>+9900.0%)
-
Dec 1998
$1.19 M
-

FAQ

  • What is Charles River Laboratories International annual long term debt?
  • What is the all time high annual long term debt for Charles River Laboratories International?
  • What is Charles River Laboratories International annual long term debt year-on-year change?
  • What is Charles River Laboratories International quarterly long term debt?
  • What is the all time high quarterly long term debt for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly long term debt year-on-year change?

What is Charles River Laboratories International annual long term debt?

The current annual long term debt of CRL is $2.72 B

What is the all time high annual long term debt for Charles River Laboratories International?

Charles River Laboratories International all-time high annual long term debt is $3.10 B

What is Charles River Laboratories International annual long term debt year-on-year change?

Over the past year, CRL annual long term debt has changed by -$342.39 M (-11.17%)

What is Charles River Laboratories International quarterly long term debt?

The current quarterly long term debt of CRL is $2.72 B

What is the all time high quarterly long term debt for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly long term debt is $3.36 B

What is Charles River Laboratories International quarterly long term debt year-on-year change?

Over the past year, CRL quarterly long term debt has changed by -$113.97 M (-4.02%)